about
Effects of postnatal exposure to a mixture of polychlorinated biphenyls, p,p'-dichlorodiphenyltrichloroethane, and p-p'-dichlorodiphenyldichloroethene in prepubertal and adult female Sprague-Dawley rats.2-Methoxyestradiol ameliorates glucose tolerance with the increase in β-cell mass in db/db mice.Estradiol-17beta and its cytochrome P450- and catechol-O-methyltransferase-derived metabolites stimulate proliferation in uterine artery endothelial cells: role of estrogen receptor-alpha versus estrogen receptor-beta.Nongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol.Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Computational study of estrogen receptor-alpha antagonist with three-dimensional quantitative structure-activity relationship, support vector regression, and linear regression methods.Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia.2-methoxyestradiol induces vasodilation by stimulating NO release via PPARγ/PI3K/Akt pathway.Gene expression signatures differ with extent of atherosclerosis in monkey iliac artery.A novel role for an endothelial adrenergic receptor system in mediating catecholestradiol-induced proliferation of uterine artery endothelial cells.Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists.Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cellsThe enhanced endothelin-1-induced contraction in cultured coronary arteries from mature female pigs is not antagonized by 17beta-estradiolStatement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Therapeutic implications of the gender-specific aspects of cardiovascular disease.Biochemical markers surrogating on vascular effects of sex steroid hormones.A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction.Vascular actions of estrogens: functional implications.Gender, sex hormones and pulmonary hypertension.Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.A transgenic mouse with vascular endothelial over-expression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: role of sexual dimorphism and age.Effectiveness of Panax ginseng on Acute Myocardial Ischemia Reperfusion Injury Was Abolished by Flutamide via Endogenous Testosterone-Mediated Akt Pathway.Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats.Potential vascular actions of 2-methoxyestradiolSerum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample.Estradiol-17β and its cytochrome P450- and catechol-O-methyltransferase-derived metabolites selectively stimulate production of prostacyclin in uterine artery endothelial cells: role of estrogen receptor-α versus estrogen receptor-β.2-methoxyestradiol in the pathophysiology of endometriosis: focus on angiogenesis and therapeutic potential.Progress in solving the sex hormone paradox in pulmonary hypertension.The Estrogen Receptors: An Overview from Different Perspectives.Regulation of CFTR channels by HCO(3)--sensitive soluble adenylyl cyclase in human airway epithelial cells.Estrogen increases the transcription of human α2-Heremans-Schmid-glycoprotein by an interplay of estrogen receptor α and activator protein-1.17beta-estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells.Influence of the Ginkgo extract EGb 761 on rat liver cytochrome P450 and steroid metabolism and excretion in rats and man.Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.Estrogen receptor-alpha mediates acute myocardial protection in females.Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value.
P2860
Q33220095-8F3085B1-E042-4106-9DC7-3B0CEEC30B78Q33585615-5D95596A-D0FD-451A-9C2D-D2C2431C98FDQ33876397-ED9898CE-2415-40DA-9668-13C43E7EC49DQ34021692-49CE540C-F553-49C0-A706-1D4BA40DA453Q34524900-F55A2A72-43D9-4B9B-9086-F7ADEB819A44Q34577697-40ECBBB3-0006-450F-B67F-E87F72170B55Q34712250-F08E1402-E25D-45C8-9674-03C0ACC31A84Q34876226-D6EC399F-F2A2-4BA8-9B5E-81AF0D9A41DCQ35154584-5B15E20A-91CD-4B0B-AE86-A7E1B1283D57Q35242266-95DF9337-2120-43AA-BE4B-E6C290E5DBE8Q35429487-99FF0F4D-4F29-4770-A1E5-3B4186D5DCA4Q35798011-26441AAD-EA2D-4949-82D8-707DAF39E798Q35878038-7F00C51B-70EE-4B68-8F8A-34CE6B898D56Q35901810-9A4244FF-25F2-4F33-B712-B4829AA6FE44Q36016478-69446FE1-8403-4E9D-8A0D-10AD9E678C50Q36467824-E6B8CD33-DE61-450A-801B-3AAAC49E31ACQ36533649-4C83AD06-935E-44BC-84F5-164D5C57323FQ36833617-380AC45B-6626-4824-903F-92C81EE04C7BQ36907389-EAA5210B-0DC2-4EB4-966B-51D7E8A74694Q37088243-D84A6336-4BE5-49A1-BDEE-B6C27434666FQ37133789-861875E4-44E4-4160-8224-9EE74882CA7AQ37174271-F5A3A52D-157F-4330-816C-D48F6751B79FQ37218720-18B50D18-F6B8-46D8-B486-D9AF6F2EB133Q37299347-DB94F80F-810D-48EE-BF2A-3D45E0A68818Q37339484-5652A6D0-F7B8-46D2-B6A7-6A885C3AB3A9Q37379821-722B720E-B64F-477E-A53A-9C2A59F9527EQ37383488-C6900BA9-9011-41CC-8C4E-DDE67AC3DAE8Q37385763-77C239FC-1B81-4121-9D60-F554E57949A8Q37442901-ECBAA136-EFCD-4877-84B6-92DFEED5ED62Q37585068-E05C527F-78C6-4108-AAFF-93A54796CDFAQ38033141-CDF0B7FD-410B-458C-A886-00C7E1624E47Q38210880-1434C9BA-CB91-441B-A12C-A0D294DFCED6Q38638935-7632D56F-75DB-498E-962E-20B173700D1BQ40409163-E71DE3F7-B5DD-43B8-A685-8ACFF85C10E2Q44515817-571662F2-2AB4-415C-8F11-5248B0BE0EFDQ44886443-DAF122A9-DA85-444D-AD3B-AFE29BB7E9EFQ46496826-F7AFB2DB-F5D3-4C7A-B74C-76EA6C6C63E6Q46731901-BDC4EF19-F692-4221-8EBD-AA9AC549D3C3Q46895528-4CD67A5F-1002-495A-BBCA-181621F81315Q47673235-B678816A-8629-4AE3-912F-2DA064E70BCA
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cardiovascular pharmacology of estradiol metabolites.
@ast
Cardiovascular pharmacology of estradiol metabolites.
@en
type
label
Cardiovascular pharmacology of estradiol metabolites.
@ast
Cardiovascular pharmacology of estradiol metabolites.
@en
prefLabel
Cardiovascular pharmacology of estradiol metabolites.
@ast
Cardiovascular pharmacology of estradiol metabolites.
@en
P2093
P356
P1476
Cardiovascular pharmacology of estradiol metabolites.
@en
P2093
Edwin K Jackson
Raghvendra K Dubey
Stevan P Tofovic
P304
P356
10.1124/JPET.103.058057
P407
P577
2003-12-01T00:00:00Z